Our work showed that C3 and C4 are qualified candidates for the treatment of wear particle-induced osteolysis.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: